New bill proposes better access to medicines in Spain
This article was originally published in Scrip
A proposal for a royal decree in Spain aims to make it easier for doctors to prescribe off-label, and for patients to access medicines still under investigation.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.